AshrafM and
CarnahanRM. Role of changing procedural characteristics versus changing risk profile in age-based trends of outcomes in patients with transfemoral transcatheter aortic valve replacement from 2012 to 2018: a nationwide analysis. J Am Heart Assoc2022; 11: e026812.
2.
MauriVAbdel-WahabMBleizifferS, et al. Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013-2020. Clin Res Cardiol2022; 111: 881–888.
3.
BhogalSRogersTAladinA, et al. TAVR in 2023: who should not get it?Am J Cardiol2023; 193: 1–18.
4.
TagliariAP and
TaramassoM. New practices in transcatheter aortic valve implantation: how I do it in 2023. J Clin Med Res. Epub ahead of print 8 February 2023. DOI: 10.3390/jcm12041342.
5.
LeonMBSmithCRMackMJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med2016; 374: 1609–1620.
6.
PalmeriniTSaiaFKimW-K, et al. Vascular access in patients with peripheral arterial disease undergoing TAVR: the Hostile registry. JACC Cardiovasc Interv2023; 16: 396–411.
7.
CarrollJDMackMJVemulapalliS, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. Ann Thorac Surg2021; 111: 701–722.
8.
BeyersdorfFBauerTFreemantleN, et al. Five-year outcome in 18 010 patients from the German Aortic Valve Registry. Eur J Cardiothorac Surg2021; 60: 1139–1146.
9.
VahanianABeyersdorfFPrazF, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg2021; 60: 727–800.
10.
Writing Committee Members, OttoCMNishimuraRA, et al. 2020ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol2021; 77: 450–500.
11.
KanekoTHirjiSAYazdchiF, et al. Association between peripheral versus central access for alternative access transcatheter aortic valve replacement and mortality and stroke: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv2022; 15: e011756.
12.
AbusninaWMachanahalli BalakrishnaAIsmaylM, et al. Comparison of transfemoral versus transsubclavian/transaxillary access for transcatheter aortic valve replacement: a systematic review and meta-analysis. Int J Cardiol Heart Vasc2022; 43: 101156.
13.
KirkerEKorngoldEHodsonRW, et al. Transcarotid versus subclavian/axillary access for transcatheter aortic valve replacement with SAPIEN 3. Ann Thorac Surg2020; 110: 1892–1897.
14.
HameedIOakleyCTHameedNUF, et al. Alternate accesses for transcatheter aortic valve replacement: a network meta-analysis. J Card Surg2021; 36: 4308–4319.
15.
ChungCJKanekoTTayalR, et al. Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience. EuroIntervention2022; 17: 1514–1522.
16.
SchäferUHoYFrerkerC, et al. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: ‘the Hamburg Sankt Georg approach’. JACC Cardiovasc Interv2012; 5: 477–486.
17.
RückAErikssonDVerouhisD, et al. Percutaneous access and closure using the MANTA vascular closure device in transaxillary transcatheter aortic valve implantation. EuroIntervention2020; 16: 266–268.
